2024-19725. Medical Devices; Dental Devices; Classification of the Neuromuscular Tongue Muscle Stimulator for the Reduction of Snoring and Obstructive Sleep Apnea  

  • Table 1—Neuromuscular Tongue Muscle Stimulator for the Reduction of Snoring and Obstructive Sleep Apnea Risks and Mitigation Measures

    Identified risks to health Mitigation measures
    Adverse tissue reaction Biocompatibility evaluation.
    Interference with other devices/electrical shock Electrical safety testing, Electromagnetic compatibility (EMC) testing, Battery safety testing, Wireless coexistence testing, and Labeling.
    Use error leading to pain, discomfort, or injury Human factors assessment; Software verification, validation, and hazard analysis; Electrical safety testing; and Labeling.
    Mucosal or skin overheating or burn Software validation, verification, hazard analysis; Electrical safety testing; Electromagnetic compatibility (EMC) testing; and Labeling.
    Infection Labeling.

Document Information

Effective Date:
9/3/2024
Published:
09/03/2024
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final amendment; final order.
Document Number:
2024-19725
Dates:
This order is effective September 3, 2024. The classification was applicable on February 5, 2021.
Pages:
71153-71155 (3 pages)
Docket Numbers:
Docket No. FDA-2024-N-3948
Topics:
Medical devices
PDF File:
2024-19725.pdf
CFR: (1)
21 CFR 872